Citations 2
PHYOX3: Long-Term Safety and Efficacy of Nedosiran in Patients with Primary Hyperoxaluria Type 1
Iraola, María Gema Ariceta, Groothoff, Jaap W. , Lipkin, Graham, Moochhala, Shabbir H. , Sellier-Leclerc, A.L., Schalk, Gesa, Rawson, Verity, Torres, Sara Estupiñan, Zhou, Jing , Höppe, Bernd , Lieske, John C. , Lipkin, Graham W., Sellier‐Leclerc, Anne‐Laure
Journal of the American Society of Nephrology | October 28, 2024 | Volume: 35 | Issue: 10S | Pages: No page available
PHYOX3: A Long-Term, Open-Label Extension Trial of Nedosiran in Patients with Primary Hyperoxaluria Type 1, 2, or 3
Schalk, Gesa, Cochat, Pierre , Lipkin, Graham, Groothoff, Jaap W. , Baum, Michelle A. , Höppe, Bernd , Roßkamp, R., Coenen, Martin , Lipkin, Graham W., Lieske, John C.
Journal of the American Society of Nephrology | May 17, 2024 | Volume: 31 | Issue: 10S | Pages: 515-515